News
Multiple rolling reviews kick-off for Novavax’s COVID-19 vaccine
Rolling reviews of Novavax’s COVID-19 vaccine have kicked-off in the UK, US, EU and Canada following the recent announcement that the jab demonstrated 89.3% efficacy in a phase III trial.